# Protalix BioTherapeutics, Inc.: Form 8-K, filed May 11, 2020

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2020-05-11
- Accepted by EDGAR: May 11, 2020, 06:06 ET
- Period: 2020-05-11
- Accession: 0001104659-20-059038
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000110465920059038/tm2018938d2_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000110465920059038/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000110465920059038/tm2018938d2_8k.htm

Filed May 11, 2020.
Source: SEC EDGAR, the filing index for accession 0001104659-20-059038. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
